• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

氯沙坦钾对5/6肾切除慢性心衰大鼠心脏的保护作用

岳娟娟, 崔寒玥, 王惠, 叶彬, 陈丁丁

岳娟娟, 崔寒玥, 王惠, 叶彬, 陈丁丁. 氯沙坦钾对5/6肾切除慢性心衰大鼠心脏的保护作用[J]. 中国药科大学学报, 2016, 47(6): 734-739. DOI: 10.11665/j.issn.1000-5048.20160617
引用本文: 岳娟娟, 崔寒玥, 王惠, 叶彬, 陈丁丁. 氯沙坦钾对5/6肾切除慢性心衰大鼠心脏的保护作用[J]. 中国药科大学学报, 2016, 47(6): 734-739. DOI: 10.11665/j.issn.1000-5048.20160617
YUE Juanjuan, CUI Hanyue, WANG Hui, YE Bin, CHEN Dingding. Protective effects of losartan potassium on 5/6 nephrectomy-induced chronic heart failure in rats[J]. Journal of China Pharmaceutical University, 2016, 47(6): 734-739. DOI: 10.11665/j.issn.1000-5048.20160617
Citation: YUE Juanjuan, CUI Hanyue, WANG Hui, YE Bin, CHEN Dingding. Protective effects of losartan potassium on 5/6 nephrectomy-induced chronic heart failure in rats[J]. Journal of China Pharmaceutical University, 2016, 47(6): 734-739. DOI: 10.11665/j.issn.1000-5048.20160617

氯沙坦钾对5/6肾切除慢性心衰大鼠心脏的保护作用

Protective effects of losartan potassium on 5/6 nephrectomy-induced chronic heart failure in rats

  • 摘要: 研究氯沙坦钾对5/6肾切除慢性心衰大鼠心脏的保护作用及其机制。将大鼠随机分为假手术组、模型组、氯沙坦钾组,除假手术组外,其余大鼠通过5/6肾切除手术建立肾衰合并心衰模型。6周后,氯沙坦钾(50 mg/L)饮水给药两周。8周末处理大鼠,测定血流动力学、心指数、血清肌酐、尿素氮,PCR测定心脏CD133、VEGFR2、Sox2表达量变化,Western blot测定的心脏cleaved Caspase 3、Bcl-2的蛋白量变化。结果显示,氯沙坦钾能明显改善5/6肾切除大鼠的心脏结构功能:心指数降低,LVDP、LVEDP降低,LVSP升高;肾功能:血清肌酐、尿素氮含量降低,并且上调心脏CD133、VEGFR2、Sox2基因表达量,Bcl-2蛋白水平,下调cleaved Caspase-3蛋白水平。氯沙坦钾能够改善慢性心衰大鼠的心衰症状,其机制可能与动员骨髓干细胞,增加内皮祖细胞数量,修复内皮功能,抑制心肌细胞凋亡相关。
    Abstract: The purpose of this research is to investigate the therapeutic effects of losartan potassium on 5/6 nephrectomy rats with chronic heart failure(CHF)and to explore the mechanism. 24 Rats were randomly divided into three groups namely sham group(Sham), pathology group(Nx)and losartan potassium group(Lst), respectively. CHF model in rats were induced by 5/6 nephrectomy. At the 7th week, rats of Lst group were given losartan potassium(50 mg/L)for consecutive 2 weeks. Then all rats were measured for hemodynamic parameters, cardiac index, creatinine, urea nitrogen in serum, and expressions of CD133, VEGFR2, Sox2, cleaved Caspase-3 and Bcl-2 in heart. Compared with Nx group, rats of Lst group improved cardiac and renal functions: decreased LVDP, LVEDP, cardiac index, creatinine, urea nitrogen and increased LVSP. Furthermore, losartan potassium up-regulated gene expression of CD133, VEGFR2, Sox2 and protein level of Bcl-2, and down-regulated cleaved Caspase-3 protein expression. Results suggest that losartan potassium can improve cardiac function of rats with CHF which may be correlated with mobilizing bone marrow stem cells, increasing endothelial progenitor cells(EPCs)level in heart, repairing endothelial function, and inhibiting myocardial apoptosis.
  • [1] Unger T,Li J.The role of the renin-angiotensin-aldosterone system in heart failure[J].J Renin Angiotensin Aldosterone Syst,2004,5(Suppl 1):S7-10.
    [2] Lund L,Benson L.Losartan vs candesartan for heart failure[J].JAMA,2012,308(4):336-337.
    [3] Wang JJ,Chen DD.Cardiorenal syndrome in 5/6 nephrectomized rats[J].Chin J Mod Drug Appl(中国现代药物应用),2009,3(15):1-4.
    [4] Remuzzi G,Perico N,Macia M,et al.The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease[J].Kidney Int,2005,68(Suppl 99):S57-65.
    [5] Zhao YH,Lu CX,Lei T,et al.The study of angiotensin Ⅱ inducing apoptosis in neonatal rat cardiomyocytes[J].Molecular Cardiol China(中国分子心脏病学杂志),2008,8(2):83-86.
    [6] Drexler H.Endothelium as a therapeutic target in heart failure[J].Circulation,1998,98(24):2652-2655.
    [7] Thal M,Krishnamurthy P,Mackie A,et al.Enhanced angiogenic and cardiomyocyte differentiation capacity of epigenetically reprogrammed mouse and human endothelial progenitor cells augments their efficacy for ischemic myocardial repair[J].Circ Res,2012,111(2):180-190.
    [8] Imanishi T,Hano T,Nishio I.Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress[J].J Hypertens,2005,23(1):97-104.
    [9] Endtmann C, Ebrahimian T, Czech T, et al. AngiotensinⅡ impairs endothelial progenitor cell number and function in vitro and in vivo:implications for vascular regeneration[J].Hypertension,2011,58(3):394-403.
    [10] Takahashi K,Yamanaka S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J].Cell,2006,126(4):663-676.
    [11] Rao JH,Zhou X.The key cell factors of stem cells Oct4 and Sox2[J].Prog Veterinary Med(动物医学进展),2012,33(3):114-119.
    [12] Liu C,Rong LM,Liu B.Sox2 induce mouse embryonic fibroblasts direct reprogrammin into neural stem cells[J].Chin J Pathophysiol(中国病理生理杂志),2015,31(1):87-92.
    [13] Tilling L,Chowienczyk P,Clapp B.Progenitors in motion:the mechanisms of mobilization of endothelial progenitor cells[J].Br J Clin Pharmacol,2009,68(4):484-492.
    [14] Kasal DA, Schiffrin EL. Angiotensin II, aldosterone, and anti-inflammatory lymphocytes:interplay and therapeutic opportunities[J].Int J Hypertens,2012,2012:829786.
    [15] Marumo T,Uchimura H,Hayashi M,et al.Aldosterone impairs bone marrow-derived progenitor cell formation[J].Hypertension,2006:48(3):490-496.
    [16] Yu Y,Fukuda N,Yao EH,et al.Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension[J].Am J Hypertens,2008,21(1):72-77.
计量
  • 文章访问数: 
  • HTML全文浏览量:  0
  • PDF下载量: 
  • 被引次数: 0
出版历程
  • 刊出日期:  2016-12-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭